Educational Development outlines 2 main-season and 2 mid-season product intros each year as sales decline narrows to 11% (NASDAQ:EDUC)October 14, 2026
Share Facebook Twitter LinkedIn Pinterest Email Marinus Pharmaceuticals GAAP EPS of -$0.42 in-line, revenue of $8.54M misses by $0.81M
Educational Development outlines 2 main-season and 2 mid-season product intros each year as sales decline narrows to 11% (NASDAQ:EDUC)October 14, 2026
By Press Room
By Press Room
By Press Room
